ECSP21082738A - Microvesículas terapéuticas de bacterias probióticas - Google Patents

Microvesículas terapéuticas de bacterias probióticas

Info

Publication number
ECSP21082738A
ECSP21082738A ECSENADI202182738A ECDI202182738A ECSP21082738A EC SP21082738 A ECSP21082738 A EC SP21082738A EC SENADI202182738 A ECSENADI202182738 A EC SENADI202182738A EC DI202182738 A ECDI202182738 A EC DI202182738A EC SP21082738 A ECSP21082738 A EC SP21082738A
Authority
EC
Ecuador
Prior art keywords
therapeutic microvesicles
probiotic bacteria
bacteria
microvesicles
therapeutic
Prior art date
Application number
ECSENADI202182738A
Other languages
English (en)
Inventor
Wolfgang Kunze
John Bienenstock
Stefan Roos
Original Assignee
Biogaia Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biogaia Ab filed Critical Biogaia Ab
Publication of ECSP21082738A publication Critical patent/ECSP21082738A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/04—Preserving or maintaining viable microorganisms
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Mycology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Nutrition Science (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

Se describe un método para proporcionar microvesículas terapéuticas de bacterias probióticas que comprende exponer las bacterias a un tratamiento inductor durante el cultivo para inducir la producción de microvesículas terapéuticas por parte de las bacterias. Las microvesículas terapéuticas se pueden utilizar en el tratamiento contra, por ejemplo, cólicos, un trastorno o enfermedad gastrointestinal infantil, un trastorno de dolor gastrointestinal, una enfermedad de pérdida ósea y/o una enfermedad periodontal.
ECSENADI202182738A 2019-04-17 2021-11-17 Microvesículas terapéuticas de bacterias probióticas ECSP21082738A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE1950483 2019-04-17
SE1951222 2019-10-25

Publications (1)

Publication Number Publication Date
ECSP21082738A true ECSP21082738A (es) 2022-01-31

Family

ID=70476308

Family Applications (1)

Application Number Title Priority Date Filing Date
ECSENADI202182738A ECSP21082738A (es) 2019-04-17 2021-11-17 Microvesículas terapéuticas de bacterias probióticas

Country Status (15)

Country Link
US (2) US11857582B2 (es)
EP (2) EP4410298A2 (es)
JP (1) JP7556881B2 (es)
KR (1) KR20220007609A (es)
CN (1) CN113747908A (es)
AU (1) AU2020258788B2 (es)
BR (1) BR112021019663A2 (es)
CA (1) CA3136978A1 (es)
CL (1) CL2021002527A1 (es)
EC (1) ECSP21082738A (es)
IL (1) IL287226A (es)
MX (1) MX2021012631A (es)
PL (1) PL3773648T3 (es)
SG (1) SG11202110355RA (es)
WO (1) WO2020214083A1 (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7556881B2 (ja) 2019-04-17 2024-09-26 バイオガイア エイビー プロバイオティック細菌の治療用マイクロベシクル
WO2022139530A1 (ko) * 2020-12-23 2022-06-30 주식회사 리스큐어바이오사이언시스 락토바실러스 사케아이 유래 세포밖 소포체를 유효성분으로 포함하는 자가면역질환의 개선, 예방 또는 치료용 조성물
CN113122478B (zh) * 2021-04-26 2022-09-06 江南大学 一株能够缓解辣椒素致胃肠损伤的副干酪乳杆菌及其用途
CN114292801A (zh) * 2021-11-22 2022-04-08 龚志术 一种益生菌菌株的驯化方法、益生菌菌株、扶微乳及其制备方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3716938A1 (de) * 1986-05-23 1987-11-26 Heise Dieter Arzneimittel zur behandlung von koliken im saeuglingsalter
US7374924B2 (en) 2006-06-05 2008-05-20 Biogaia Ab Use of selected lactic acid bacteria for reducing infantile colic
US8617537B2 (en) 2008-06-10 2013-12-31 Biogaia Ab Controlled activation of the reuterin-production machinery of lactobacillus
CN103079592B (zh) * 2010-07-01 2015-10-21 浦项工科大学校产学协力团 使用来自细胞的微泡治疗和诊断癌症的方法
JP6858406B2 (ja) 2015-07-27 2021-04-14 セティ株式会社 乳酸菌組成物、発酵乳及びその製造方法、並びに発酵乳製造キット
KR102394638B1 (ko) 2015-09-30 2022-05-09 (주)아모레퍼시픽 유산균 유래의 세포외 소낭을 포함하는 탈모 방지 또는 육모 촉진용 조성물
MX2019013143A (es) * 2017-05-05 2020-07-14 Nestle Sa Tratamiento de colicos infantiles.
KR101853603B1 (ko) 2017-05-18 2018-05-02 주식회사 쎌바이오텍 알코올 또는 아세트알데하이드 분해용 프로바이오틱스를 포함하는 조성물
US12059442B2 (en) 2018-03-29 2024-08-13 Morinaga Milk Industry Co., Ltd. Obesity treatment using probiotics, composition for reducing body fat, and composition for reducing waist circumference
JP7556881B2 (ja) 2019-04-17 2024-09-26 バイオガイア エイビー プロバイオティック細菌の治療用マイクロベシクル

Also Published As

Publication number Publication date
IL287226A (en) 2021-12-01
BR112021019663A2 (pt) 2021-12-07
AU2020258788B2 (en) 2024-07-04
US20210154245A1 (en) 2021-05-27
CN113747908A (zh) 2021-12-03
CA3136978A1 (en) 2020-10-22
PL3773648T3 (pl) 2024-08-26
WO2020214083A1 (en) 2020-10-22
EP3773648A1 (en) 2021-02-17
MX2021012631A (es) 2021-11-12
EP4410298A2 (en) 2024-08-07
EP3773648C0 (en) 2024-06-19
CL2021002527A1 (es) 2022-04-22
AU2020258788A1 (en) 2021-10-28
US20240082325A1 (en) 2024-03-14
JP7556881B2 (ja) 2024-09-26
KR20220007609A (ko) 2022-01-18
EP3773648B1 (en) 2024-06-19
US11857582B2 (en) 2024-01-02
SG11202110355RA (en) 2021-11-29
JP2022529456A (ja) 2022-06-22

Similar Documents

Publication Publication Date Title
ECSP21082738A (es) Microvesículas terapéuticas de bacterias probióticas
AR087003A1 (es) Dispositivo separador modular para el tratamiento de infecciones de la protesis de miembros humanos
CO2017007383A2 (es) Métodos para utilizar oligonucleótidos antisentido para smad7
CO2023001509A2 (es) Cepa c de prevotella histicola como terapia oral para enfermedades inflamatorias
CO2020014673A2 (es) Selección y uso de bacterias que apoyan la melatonina para reducir el cólico del lactante
RU2013153030A (ru) Способ введения лекарственного препарата на постоперационную рану при непосредственном зубном или челюстном протезировании
Sevbitov et al. Experimental substantiation of the bactericidal effect of sodium hypochlorite on the microflora of a purulent wound with odontogenic phlegmons of the face and neck
RU2014107682A (ru) Способ получения миобластов, использование биоптата десны, препарат миобластов для лечения патологий мышечной ткани и способ его получения
JP1735109S (ja) 医療用電極
JP1735110S (ja) 医療用電極
CN204581924U (zh) 治疗性功能障碍的保健按摩环
NZ740722A (en) Oral suspension for treating eosinophilic esophagitis
JP1736001S (ja) 医療用包帯
UA126148U (uk) Спосіб лікування періімплантного мукозиту
RU2014124801A (ru) Способ комплексного лечения больных с язвенной болезнью желудка и двенадцатиперстной кишки
JP1783702S (ja) スキントリートメント用先端器具
MX2023006765A (es) Metodo para proporcionar terapia de celiprolol a un paciente.
MD1406Y (ro) Metodă de tratament al afecţiunilor inflamatorii ale parodonţiului şi mucoasei cavităţii bucale
RU2010140179A (ru) Способ лечения пародонтита - способ иорданишвили
RU2013153574A (ru) Способ лечения синовитов и/или синовиальных кист
JP1731407S (ja) 滅菌装置
LV15557A (lv) Metode ūdens dezinfekcijai, izmantojot CaFeO
Barbara Niesel Aromatherapy Use in Patients with Dementia: A Case Study
UA113699C2 (uk) Спосіб лікування інфекції helicobacter pylori
UA114464U (xx) Спосіб лікування атеросклерозу